Canada Must Show Leadership for Global Fund’s 8th Replenishment – Organizational Sign-on Letter

Please click here to add your organization’s name to this open letter.

The Right Honourable Mark Carney, P.C., M.P.
Prime Minister of Canada
80 Wellington Street
Ottawa, Ontario
K1A 0A2

Dear Prime Minister

The Eighth Replenishment of the Global Fund to Fight AIDS, Tuberculosis (TB) and Malaria (the Global Fund) will take place in November this year, co-hosted by the Republic of South Africa and the United Kingdom. This marks a pivotal moment in the fight against the world’s three deadliest infectious diseases and in our progress on delivering the 2030 Agenda for Sustainable Development ensuring that No One Is Left Behind

Canada has long been a crucial partner as the seventh largest funder of the Global Fund and an ardent defender of human rights, gender equality, and global health. Canada’s continued leadership on the global stage is more critical than ever. As the 2025 President of the G7 and a longstanding partner of the Global Fund, Canada’s bold pledge to the Eighth Replenishment is one of the most effective ways to save lives, improve the health of millions, protect human rights, and reinforce global security and prosperity for all. As the G7 President and an alumni host of a Global Fund Replenishment (2016), Canada now holds a particular diplomatic role, responsibility and privilege to lead by example, setting the bar for other governments to follow.

We, the undersigned organizations, represent communities affected by HIV, TB, and malaria, as well as civil society allies in Canada and around the world. Together, we are calling on the Government of Canada to demonstrate its continued leadership in global health and human rights with a pledge of CAD$457 million per year (CAD$1.37 billion over three years) to the Global Fund’s Eighth Replenishment. 

Good health and well-being (SDG 3) are both a cause and a consequence of sustainable development. They are decisive foundations for ensuring strong, productive, and resilient societies with extensive evidence showing immense return on investment, economic benefit for other sectors, and value for money. Investing in the Global Fund is a strategic choice that closely aligns with Canada’s priorities of global leadership and security, inclusive economic growth, human rights protections, gender equality, and sustainable development.

Over the past two decades, working hand-in-hand with communities most affected by the three diseases, governments (implementers and donors), the private sector, civil society and technical partners, the Global Fund partnership has saved 70 million lives. Together, our impact has been monumental. For instance, incidence rates across the three diseases have fallen by 42% and we have successfully achieved a 63% reduction in the combined death rate from AIDS, TB, and malaria. These investments in health not only save lives, they bolster communities, strengthen critical health systems and essential infrastructure, and drive economic productivity and broader socioeconomic development.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below